de-la-Motte Pernille, Jensen Victoria Baekager Just, Bergum Maria Højer, Mose Frank Holden, Khatir Dinah Sherzad, Finderup Jeanette
Department of Public Health, Aarhus University, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
BMC Nephrol. 2025 Jun 5;26(1):282. doi: 10.1186/s12882-025-04220-1.
The 'Shared decision making and dialysis choice' intervention has been part of usual care at two hospitals in Denmark since 2018. The objective was to describe dialysis modality choice and outcomes for patients with kidney failure who received a shared decision making intervention.
Retrospective observational longitudinal cohort study design was used. Data were collected from 2018 to 2023 on 484 patients with kidney failure from one regional and one university hospital. The exposure was a shared decision making intervention for dialysis choice. The predictors were frailty, estimated glomerular filtration rate (eGFR), comorbidity, Body Mass Index (BMI), ethnicity, marital status and smoking. The outcomes were home-based dialysis, time, concordance, and death. Fisher's exact tests and Wilcoxon rank-sum tests assessed whether choice of dialysis modality differed significantly. Aalen-Johansen estimation assessed time from the shared decision making intervention to treatment initiation, concordance between chosen and initiated treatment, and mortality before treatment initiation. Logistic regression and Cox proportional hazards evaluated the patient characteristics predicting these three outcomes.
After the intervention, 68% chose home-based dialysis, while 32% chose center-based dialysis. With significant differences, more patients aged ≤ 70 years, at the university hospital, and living with a partner chose home-based dialysis. Half of the patients initiated treatment within 11 months, and predictors for initiating dialysis later than 11 months were age ≥ 70 years and eGFR > 15 ml/min/1.73 m². 83% of the patients received the treatment chosen, and predictors for concordance were center-based dialysis, regional hospital, and very mild to mild frailty. 12% of the patients died before treatment initiation, predicted by very mild to severe frailty and BMI < 25 kg/m².
A high proportion of patients chose a home-based treatment after receiving the intervention and initiated their preferred dialysis choice. 50% of patients received the intervention 11 months before initiating dialysis, and few patients died before initiating dialysis. Routinely assessing frailty and BMI prior to intervention could possibly improve patient pathways. Complete follow-up for all patients was not ensured.
自2018年以来,“共同决策与透析选择”干预措施一直是丹麦两家医院常规护理的一部分。目的是描述接受共同决策干预的肾衰竭患者的透析方式选择及结果。
采用回顾性观察性纵向队列研究设计。收集了2018年至2023年来自一家地区医院和一家大学医院的484例肾衰竭患者的数据。暴露因素为透析选择的共同决策干预。预测因素为虚弱、估计肾小球滤过率(eGFR)、合并症、体重指数(BMI)、种族、婚姻状况和吸烟情况。结果指标为居家透析、时间、一致性和死亡情况。Fisher精确检验和Wilcoxon秩和检验评估透析方式的选择是否存在显著差异。Aalen-Johansen估计法评估从共同决策干预到开始治疗的时间、所选治疗与开始治疗之间的一致性以及开始治疗前的死亡率。逻辑回归和Cox比例风险模型评估预测这三个结果的患者特征。
干预后,68%的患者选择居家透析,而32%的患者选择中心透析。存在显著差异的是,更多年龄≤70岁、在大学医院且有伴侣陪伴的患者选择居家透析。一半的患者在11个月内开始治疗,而开始透析时间晚于11个月的预测因素为年龄≥70岁和eGFR>15 ml/min/1.73 m²。83%的患者接受了所选治疗,一致性的预测因素为中心透析、地区医院以及非常轻度至轻度虚弱。12%的患者在开始治疗前死亡,预测因素为非常轻度至重度虚弱和BMI<25 kg/m²。
接受干预后,很大比例的患者选择了居家治疗并开始了他们首选的透析方式。50%的患者在开始透析前11个月接受了干预,很少有患者在开始透析前死亡。在干预前常规评估虚弱和BMI可能会改善患者就医流程。未确保对所有患者进行完整随访。